Metastatic Thyroid Cancer
5 clinical trials · Condition
◉ Watch Metastatic Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC (NCT05668962) | Massachusetts General Hospital | 2023-03-01 |
| Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial (NCT03753919) | Grupo Espanol de Tumores Neuroendocrinos | 2019-04-02 |
| Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition (NCT04619316) | University Hospital, Essen | 2018-02-05 |
| Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer (NCT03099356) | University of Michigan Rogel Cancer Center | 2017-04-27 |
| Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer (NCT02390739) | National Cancer Institute (NCI) | 2015-03-02 |
Track Metastatic Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.